[Federal Register Volume 86, Number 101 (Thursday, May 27, 2021)]
[Notices]
[Pages 28633-28634]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-11255]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Agency Emergency Information Collection Clearance Request for 
Public Comment

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the requirement of the Paperwork Reduction 
Act of 1995 to provide opportunity for public comment on proposed data 
collection projects, the National Institutes of Health (NIH) will 
publish periodic summaries of propose projects to be submitted to the 
Office of Management and Budget (OMB) for review and approval.

DATES: Comments on the information collection request must be received 
on or before 10 days of this published notice.

ADDRESSES: When commenting, please reference the document identifier or 
OMB control number. To be assured consideration, comments and 
recommendations must be submitted within 10 days. You may send your 
comments electronically to http://www.regulations.gov. Follow the 
instructions for ``Comment or Submission'' or ``More Search Options'' 
to find the information collection document(s) that are accepting 
comments.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection

[[Page 28634]]

plans and instruments, submit comments in writing, or request more 
information on the proposed project, contact: Ms. Mikia P. Currie, 
Office of Policy for Extramural Research Administration, 6705 Rockledge 
Drive, Suite 350, Bethesda, Maryland 20892, or call a non-toll-free 
number 301-435-0941 or Email your request, including your address to 
[email protected]. Formal requests for additional 
plans and instruments must be requested in writing.

SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork 
Reduction Act of 1995 requires: Written comments and/or suggestions 
from the public and affected agencies are invited to address one or 
more of the following points: (1) The necessity and utility of the 
proposed information collection for the proper performance of the 
agency's functions; (2) the accuracy of the estimated burden; (3) ways 
to enhance the quality, utility, and clarity of the information to be 
collected; and (4) the use of automated collection techniques or other 
forms of information technology to minimize the information collection 
burden.
    Title of the Collection: Audience Feedback to Inform Ongoing 
Messaging and Strategies for ``Combat COVID''
    Type of Collection: Emergency.

OMB No. 0925-NEW--Federal COVID Response

    Abstract: The Federal COVID Response (FCR) Team is a cross-agency 
partnership that includes the U.S. Department of Health and Human 
Services (HHS), including the National Institutes of Health (NIH) 
Office of the Director, Centers for Disease Control and Prevention 
(CDC), the U.S. Food and Drug Administration (FDA), the Biomedical 
Advanced Research and Development Authority (BARDA), and the U.S. 
Department of Defense (DOD). The FCR Team oversees the ``Combat COVID'' 
initiative--a multifaceted effort to provide the general public and 
healthcare providers with the latest evidence-based information on 
COVID-19 treatments and the Accelerating COVID-19 Therapeutic 
Interventions and Vaccines (ACTIV) clinical trials (including the 
combatcovid.hhs.gov website). The NIH is especially interested in 
recruiting participants from groups who have historically been 
underrepresented in clinical trials. Together with their contractor, 
the FCR Team is working to:
     Address participation barriers and raise awareness of 
ACTIV clinical trials, and
     Ensure the general public's and health care provider's 
needs are met as it pertains to evidence-based information on these 
trials.
    The purpose of the information collection is to collect routine 
feedback from the Combat COVID Initiative's two target audiences (the 
general public and healthcare providers) to identify evolving needs and 
better disseminate relevant information relates to COVID-19 treatment 
and ACTIV clinical trial resources. Because the COVID-19 treatment 
landscape continues to evolve and audience needs continue to change, it 
is critical for the FCR Team to collect routine feedback from the 
general public (especially from groups who have not historically been 
well-represented in clinical trials) and healthcare providers to 
identify these evolving needs. By understanding evolving needs, the FCR 
team will be able to properly develop and broadly disseminate relevant 
COVID-19 treatment and ACTIV clinical trial resources. This effort will 
require ongoing data collection over the next 20 months (through the 
end of December 2022).
    Data collected through this effort will be used to inform the 
development and broad dissemination of Combat COVID resources, 
including new or enhanced messages, materials and/or web pages 
(combatcovid.hhs.gov).
    The team will employ two strategies to collect this routine 
audience feedback:
    1. DATA COLLECTION STRATEGY 1: Monthly 60-minute virtual audience 
feedback teams sessions (focus groups, in-depth interviews, online 
bulletin boards) for rapid testing of new Combat COVID messages, 
concepts, ideas, resources, web pages, and materials.
    2. DATA COLLECTION STRATEGY 2: 15-minute custom web surveys to 
understand target audiences' needs and awareness of Combat COVID over 
time, and to inform ongoing messages and strategies.

                                        Estimated Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of        Number        burden per     Total burden
               Type of respondent                   respondents    responses per   response  (in       hours
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Consumer Audience Feedback Team Screener                     120               1            5/60              10
 (Attachment 1).................................
HCP Audience Feedback Team Screener (Attachment               40               1            5/60               3
 2).............................................
Consumer Audience Feedback Activity (Attachments              60              12               1             720
 3 & 5).........................................
HCP Audience Feedback Activity (Attachments 4 &               20              12               1             240
 5).............................................
Benchmark & Follow-Up Web Surveys--Consumer                2,000               5           15/60           2,500
 Audience (Attachment 6)........................
Benchmark & Follow-Up Web Survey--HCP Audience               300               5           15/60             375
 (Attachment 6).................................
                                                 ---------------------------------------------------------------
    Total.......................................           2,540          12,620  ..............            3848
----------------------------------------------------------------------------------------------------------------


    Dated: May 20, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-11255 Filed 5-26-21; 8:45 am]
BILLING CODE 4140-01-P